Zydus Lifesciences Q4 Results: Consolidated net profit dips 25 pc to Rs 297 crore, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

​​The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, mentioned its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the Annual General Meeting scheduled to be held on August 11, 2023., ​​The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, mentioned its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the Annual General Meeting scheduled to be held on August 11, 2023., , Read More

Leave a Reply

Your email address will not be published.